1. Web alert

   OriginalPaper 04 May 2008 Pages: 1 - 2

2. The benefit of nonpharmacologic therapy to treat symptomatic osteoarthritis

   • Yvonne C. Lee
   • Robert H. Shmerling

   OriginalPaper 04 May 2008 Pages: 5 - 10

3. Abuse-deterrent opioid formulations: Are they a pipe dream?

   • Nathaniel Katz

   OriginalPaper 04 May 2008 Pages: 11 - 18

4. Are there promising biologic therapies for osteoarthritis?

   • David J. Hunter

   OriginalPaper 04 May 2008 Pages: 19 - 25

5. Lessons from animal models of osteoarthritis

   • Wim B. van den Berg

   OriginalPaper 04 May 2008 Pages: 26 - 29

6. Extracellular matrix and pathogenic mechanisms in osteoarthritis

   • Tim Hardingham

   OriginalPaper 04 May 2008 Pages: 30 - 36

7. Cell death in osteoarthritis

   • Marcello Del Carlo Jr
   • Richard F. Loeser

   OriginalPaper 04 May 2008 Pages: 37 - 42

8. Licofelone: The answer to unmet needs in osteoarthritis therapy?

   • Shrinivas K. Kulkarni
   • Vijay Pal Singh

   OriginalPaper 04 May 2008 Pages: 43 - 48

9. The Post-NSAID Era: What to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis

   • Carla R. Scanzello
   • Neal K. Moskowitz
   • Allan Gibofsky

   OriginalPaper 04 May 2008 Pages: 49 - 56

10. Primary thrombosis prevention in aPL-positive patients

    • Kathleen M. O’Neil

    Clinical Trials Report 04 May 2008 Pages: 59 - 61

11. Thrombolysis in antiphospholipid syndrome: Current hematologic perspectives

    • René Y. McNall-Knapp

    OriginalPaper 04 May 2008 Pages: 62 - 66

12. Neurologic manifestations of the antiphospholipid syndrome: Integrating molecular and clinical lessons

    • Eyal Muscal
    • Robin L. Brey

    OriginalPaper 04 May 2008 Pages: 67 - 73

13. The enigmas of the lupus anticoagulant: Mechanisms, diagnosis, and management

    • Richard A. Marlar
    • Sanam Husain

    OriginalPaper 04 May 2008 Pages: 74 - 80